AK Medical Holdings Ltd (AK Medical) has filed a Next Day Disclosure Return to the Hong Kong Stock Exchange dated 2 April 2026, detailing its recent share buy-back activities and the resulting capital position.

The company’s issued share capital stood unchanged at 1.12 billion ordinary shares both before and after the reporting date. No treasury shares were held.

Between 6 February and 2 April 2026, AK Medical repurchased a total of 4.26 million shares that have not yet been cancelled. The six on-market transactions were executed at prices ranging from HKD 5.92 to HKD 6.40 per share, equivalent to 0.38% of the current issued share base. The latest buy-back, completed on 2 April 2026, involved 100,000 shares at HKD 6.40 each for a consideration of HKD 0.64 million.

Under the general mandate approved on 18 June 2025, the board is authorised to repurchase up to 112.27 million shares. Cumulative repurchases under this mandate now total 4.26 million shares, representing 3.80% of the company’s share capital at the mandate date.

Pursuant to Hong Kong listing rules, AK Medical is restricted from issuing new shares for 30 days following the latest repurchase, setting a moratorium that runs through 2 May 2026.